AU778767C - Novel diphenylethylene compounds - Google Patents

Novel diphenylethylene compounds

Info

Publication number
AU778767C
AU778767C AU40857/99A AU4085799A AU778767C AU 778767 C AU778767 C AU 778767C AU 40857/99 A AU40857/99 A AU 40857/99A AU 4085799 A AU4085799 A AU 4085799A AU 778767 C AU778767 C AU 778767C
Authority
AU
Australia
Prior art keywords
compound
hydrogen
ome
composition according
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU40857/99A
Other languages
English (en)
Other versions
AU778767B2 (en
AU4085799A (en
Inventor
Debendranath Dey
Satyanarayana Medicherla
Bishwajit Nag
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Theracos Inc
Original Assignee
Theracos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theracos Inc filed Critical Theracos Inc
Publication of AU4085799A publication Critical patent/AU4085799A/en
Assigned to THERACOS, INC. reassignment THERACOS, INC. Alteration of Name(s) of Applicant(s) under S113 Assignors: CALYX THERAPEUTICS, INC.
Application granted granted Critical
Publication of AU778767B2 publication Critical patent/AU778767B2/en
Publication of AU778767C publication Critical patent/AU778767C/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C15/00—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts
    • C07C15/40—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts substituted by unsaturated carbon radicals
    • C07C15/50—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts substituted by unsaturated carbon radicals polycyclic non-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/215—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring having unsaturation outside the six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU40857/99A 1999-05-18 1999-05-18 Novel diphenylethylene compounds Ceased AU778767C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1999/011001 WO2000069430A1 (en) 1999-05-18 1999-05-18 Novel diphenylethylene compounds

Publications (3)

Publication Number Publication Date
AU4085799A AU4085799A (en) 2000-12-05
AU778767B2 AU778767B2 (en) 2004-12-23
AU778767C true AU778767C (en) 2006-09-07

Family

ID=22272785

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40857/99A Ceased AU778767C (en) 1999-05-18 1999-05-18 Novel diphenylethylene compounds

Country Status (9)

Country Link
EP (1) EP1178788A4 (enExample)
JP (1) JP2002544227A (enExample)
KR (1) KR100598638B1 (enExample)
CN (1) CN1194674C (enExample)
AU (1) AU778767C (enExample)
CA (1) CA2373603A1 (enExample)
HK (1) HK1046642B (enExample)
MX (1) MXPA01011760A (enExample)
WO (1) WO2000069430A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7323496B2 (en) 1999-11-08 2008-01-29 Theracos, Inc. Compounds for treatment of inflammation, diabetes and related disorders
MXPA02007514A (es) * 2000-02-04 2004-02-26 Calyx Therapeutics Inc Compuestos novedosos de difeniletileno.
US6552085B2 (en) 2000-08-16 2003-04-22 Insmed Incorporated Compositions containing hypoglycemically active stilbenoids
US6410596B1 (en) * 2000-08-16 2002-06-25 Insmed Incorporated Compositions containing hypoglycemically active stillbenoids
CN1398838A (zh) 2001-07-26 2003-02-26 中国人民解放军军事医学科学院放射医学研究所 二苯乙烯类化合物制备以及它们在治疗和预防糖尿病中的应用
JP4781580B2 (ja) * 2001-09-26 2011-09-28 日本メナード化粧品株式会社 コラゲナーゼ阻害剤
US20050096256A1 (en) 2003-07-01 2005-05-05 President And Fellows Of Harvard College Compositions for manipulating the lifespan and stress response of cells and organisms
EP1708689A2 (en) 2003-12-29 2006-10-11 The President and Fellows of Harvard College Compositions for treating or preventing obesity and insulin resistance disorders
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
CN1723884A (zh) * 2004-07-21 2006-01-25 中国人民解放军军事医学科学院放射医学研究所 顺式－1，2－取代的二苯乙烯衍生物用于制备治疗或预防糖尿病的药物的用途
WO2006138418A2 (en) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
CN100384801C (zh) * 2006-06-23 2008-04-30 中国科学院广州化学研究所 (e)-3,5-二甲氧基-4＇-羟基二苯乙烯的合成方法
FR2904311B1 (fr) 2006-07-28 2013-01-11 Clariant Specialty Fine Chem F Nouveau procede de synthese de derives (e) stilbeniques perm permettant d'obtenir le resveratrol et le piceatannol
FR2921921B1 (fr) 2007-10-03 2011-08-19 Clariant Specialty Fine Chem F Procede de synthese de composes polyhydroxystilbeniques.
CN107324976B (zh) * 2017-07-28 2020-06-16 安徽理工大学 一种制备(E)-β-烷基苯乙烯类化合物的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314693A (en) * 1992-02-07 1994-05-24 Kioritz Corporation Pest control chemicals against pine wood nematodes
US5430062A (en) * 1992-05-21 1995-07-04 Research Corporation Technologies, Inc. Stilbene derivatives as anticancer agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770620A (en) * 1995-06-19 1998-06-23 Ontogen Corporation Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
US5827898A (en) * 1996-10-07 1998-10-27 Shaman Pharmaceuticals, Inc. Use of bisphenolic compounds to treat type II diabetes
FR2778337B1 (fr) * 1998-05-05 2001-08-31 Inst Nat Sante Rech Med Antagonistes des ligands du recepteur des arylhydrocarbures

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314693A (en) * 1992-02-07 1994-05-24 Kioritz Corporation Pest control chemicals against pine wood nematodes
US5430062A (en) * 1992-05-21 1995-07-04 Research Corporation Technologies, Inc. Stilbene derivatives as anticancer agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PETTTIT ET AL. J. NAT. PROD., 1998, 51(3), 517-27 *

Also Published As

Publication number Publication date
HK1046642B (zh) 2005-11-25
MXPA01011760A (es) 2003-09-04
EP1178788A4 (en) 2005-08-10
JP2002544227A (ja) 2002-12-24
KR100598638B1 (ko) 2006-07-07
EP1178788A1 (en) 2002-02-13
KR20020012220A (ko) 2002-02-15
HK1046642A1 (en) 2003-01-24
WO2000069430A1 (en) 2000-11-23
AU778767B2 (en) 2004-12-23
CN1354659A (zh) 2002-06-19
CA2373603A1 (en) 2000-11-23
AU4085799A (en) 2000-12-05
CN1194674C (zh) 2005-03-30

Similar Documents

Publication Publication Date Title
US6245814B1 (en) Diphenylethylene compounds
AU778767B2 (en) Novel diphenylethylene compounds
US5827898A (en) Use of bisphenolic compounds to treat type II diabetes
US6624197B1 (en) Diphenylethylene compounds
CA2637884A1 (en) Compounds for the treatment of metabolic disorders
WO1996039133A1 (en) Novel n-substituted-2-amino-3',4'-methylene-dioxypropiophenones
US6448450B1 (en) 1-(3,5-dimethoxyphenyl)-2-(4-hydroxyphenyl)-ethylene for diabetes treatment
US6855732B2 (en) Compounds to treat diabetes and associated conditions
US20040259938A1 (en) Novel dipheylenthylene compounds
KR101391905B1 (ko) 물질대사 장애의 치료용 화합물
US7005539B2 (en) Ferulic acid dimers and their pharmaceutically acceptable salts, their preparation and use thereof for treating dementia
KR100479405B1 (ko) 신남산 이합체, 그 제조방법 및 퇴행성 뇌질환 치료를위한 그의 용도
NZ511065A (en) Diphenylethylene (stillbenzenes) compounds for treating diabetes
AU784974B2 (en) Novel diphenylethylene compounds
CN108403980B (zh) 一种降血糖植物提取物有效部位及其制备方法和应用
DE69200810T2 (de) Benzoesäureethanolaminesterderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
KR100784958B1 (ko) 신규한 디페닐에틸렌 화합물
EP0080011A1 (en) Novel compounds with antiinflammatory and analgesic activity, process for the preparation thereof and pharmaceutical compositions therefrom

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: THERACOS, INC.

Free format text: THE FORMER OWNER WAS: CALYX THERAPEUTICS, INC.